Clinical Trial: Efficacy of Botulinum Toxin A Versus Nanofat in the Treatment of Androgenetic Alopecia: A Comparative Clinical Trial

U.S., Oct. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07863856) titled 'Efficacy of Botulinum Toxin A Versus Nanofat in the Treatment of Androgenetic Alopecia: A Comparative Clinical Trial' on Sept. 28.

Brief Summary: The goal of this clinical trial is to learn whether botulinum toxin A (BTA) or autologous nanofat injection is more effective for treating male androgenetic alopecia. It will also assess the safety of both treatments. The main questions it aims to answer are:

* Does botulinum toxin A or nanofat produce a greater increase in total hair count after 6 months?

* How do the treatments affect terminal hairs, vellus hairs, hair shaft characteristics, and other dermoscopic features?

* What side ...